Search Results

There are 18206 results for: content related to: Antidepressant Effects on Emotional Temperament: Toward a Biobehavioral Research Paradigm for Major Depressive Disorder

  1. You have free access to this content
    The Selective Norepinephrine Reuptake Inhibitor Antidepressant Reboxetine: Pharmacological and Clinical Profile

    CNS Drug Reviews

    Volume 10, Issue 1, March 2004, Pages: 23–44, Mihály Hajós, Joseph C. Fleishaker, Jacqueline K. Filipiak-Reisner, Mark T. Brown and Erik H. F. Wong

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00002.x

  2. You have free access to this content
    Paroxetine versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Marianna Purgato, Davide Papola, Chiara Gastaldon, Carlotta Trespidi, Laura R Magni, Carla Rizzo, Toshi A Furukawa, Norio Watanabe, Andrea Cipriani and Corrado Barbui

    Published Online : 3 APR 2014, DOI: 10.1002/14651858.CD006531.pub2

  3. You have free access to this content
    Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetine

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 389–398, Neil Benson, Nelleke Snelder, Bart Ploeger, Carolyn Napier, Harriet Sale, Nigel JM Birdsall, Richard P Butt and Piet H van der Graaf

    Version of Record online : 3 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00719.x

  4. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study

    Human Psychopharmacology: Clinical and Experimental

    Volume 21, Issue 5, July 2006, Pages: 337–345, Cengiz Akkaya, Enver Yusuf Sivrioglu, Semra Akgoz, Salih Saygin Eker and Selcuk Kirli

    Version of Record online : 20 JUL 2006, DOI: 10.1002/hup.770

  5. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 246–255, CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, R Brenneisen, J Huwyler and ME Liechti

    Version of Record online : 15 JUN 2011, DOI: 10.1038/clpt.2011.78

  6. You have free access to this content
    Fluoxetine versus other types of pharmacotherapy for depression

    Intervention Review

    The Cochrane Library

    Laura R Magni, Marianna Purgato, Chiara Gastaldon, Davide Papola, Toshi A Furukawa, Andrea Cipriani and Corrado Barbui

    Published Online : 17 JUL 2013, DOI: 10.1002/14651858.CD004185.pub3

  7. Lack of effect of reboxetine on cardiac repolarization

    Clinical Pharmacology & Therapeutics

    Volume 70, Issue 3, September 2001, Pages: 261–269, Joseph C. Fleishaker, Steven F. Francom, Beth D. Herman, Dean W. Knuth and Nkechi E. Azie

    Version of Record online : 27 SEP 2001, DOI: 10.1067/mcp.2001.117705

  8. Monoaminergic-based Pharmacotherapy for Depression

    Biology of Depression: From Novel Insights to Therapeutic Strategies

    George I. Papakostas, Maurizio Fava, Pages: 87–209, 2008

    Published Online : 29 JAN 2008, DOI: 10.1002/9783527619672.ch6

  9. Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 4, October 1999, Pages: 374–379, Beth D. Herman, Joseph C. Fleishaker and Mark T. Brown

    Version of Record online : 14 OCT 1999, DOI: 10.1053/cp.1999.v66.a101207

  10. Hemodynamic effects of reboxetine in healthy male volunteers

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 3, September 1999, Pages: 282–287, Thierry Denolle, Cinzia Pellizzoni, M. Gabriella Jannuzzo and Italo Poggesi

    Version of Record online : 26 SEP 1999, DOI: 10.1016/S0009-9236(99)70036-6

  11. You have free access to this content
    The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy

    Epilepsia

    Volume 53, Issue 5, May 2012, Pages: 870–878, Katia Vermoesen, Ann Massie, Ilse Smolders and Ralph Clinckers

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1528-1167.2012.03436.x

  12. You have free access to this content
    Citalopram versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Marianna Purgato, Toshi A Furukawa, Carlotta Trespidi, Giuseppe Imperadore, Alessandra Signoretti, Rachel Churchill, Norio Watanabe and Corrado Barbui

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD006534.pub2

  13. Reboxetine, a selective noradrenaline reuptake inhibitor, is non-sedative and does not impair psychomotor performance in healthy subjects

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue 6, August 1998, Pages: 425–433, Werner M. Herrmann and Hermann Fuder

    Version of Record online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199808)13:6<425::AID-HUP17>3.0.CO;2-R

  14. Reboxetine in the maintenance therapy of depressive disorder in the elderly: a long-term open study

    International Journal of Geriatric Psychiatry

    Volume 15, Issue 9, September 2000, Pages: 784–793, Eugenio Aguglia

    Version of Record online : 7 SEP 2000, DOI: 10.1002/1099-1166(200009)15:9<784::AID-GPS189>3.0.CO;2-Z

  15. Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue S1, February 1998, Pages: S29–S39, T. A. Ban, P. Gaszner, E. Aguglia, R. Batista, A. Castillo, A. Lipcsey, J.-P. Macher, A. Torres-Ruiz and L. Vergara

    Version of Record online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199802)13:1+<S29::AID-HUP980>3.0.CO;2-D

  16. You have free access to this content
    The Promises and Pitfalls of Reboxetine

    CNS Drug Reviews

    Volume 9, Issue 4, December 2003, Pages: 327–342, Michelle E. Page

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2003.tb00258.x

  17. You have free access to this content
    Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize α2-adrenoceptors in the prefrontal cortex

    British Journal of Pharmacology

    Volume 132, Issue 1, January 2001, Pages: 183–188, R W Invernizzi, S Parini, G Sacchetti, C Fracasso, S Caccia, K Annoni and R Samanin

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703821

  18. Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics

    Biopharmaceutics & Drug Disposition

    Volume 20, Issue 1, January 1999, Pages: 53–57, Joseph C. Fleishaker, Massimiliano Mucci, Cinzia Pellizzoni and Italo Poggesi

    Version of Record online : 14 APR 1999, DOI: 10.1002/(SICI)1099-081X(199901)20:1<53::AID-BDD157>3.0.CO;2-P

  19. Iodine-123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography

    Synapse

    Volume 66, Issue 11, November 2012, Pages: 923–930, Adriana Alexandre S. Tavares, Nicola K. Jobson, Deborah Dewar, Andrew Sutherland, Sally L. Pimlott, Jeffery Batis, Olivier Barret, John Seibyl and Gilles Tamagnan

    Version of Record online : 30 JUL 2012, DOI: 10.1002/syn.21585

  20. Pharmacokinetics of Single-Dose Reboxetine in Volunteers with Renal Insufficiency

    The Journal of Clinical Pharmacology

    Volume 40, Issue 5, May 2000, Pages: 482–487, Dr. François Coulomb, Dr. Francis Ducret, Mr. Jean-Paul Laneury, Dr. Francesco Fiorentini, Dr. Italo Poggesi, Dr. M. Gabriella Jannuzzo, Dr. Joseph C. Fleishaker, Dr. Georges Houin and Dr. Patrick Duchêne

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700022009251